Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...

Obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust results with the new medications.

Obesity is a chronic, progressive disease that can lead to serious health complications, reduced quality of life, and ...

If you are someone who has recently managed to shed your extra weight with the help of a new blockbuster GLP-1 drug then you ...

So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you ...

In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth ...